ChenGuang Biotech Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
ChenGuang Biotech Group has a total shareholder equity of CN¥3.1B and total debt of CN¥4.0B, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are CN¥7.7B and CN¥4.6B respectively. ChenGuang Biotech Group's EBIT is CN¥311.5M making its interest coverage ratio 4.9. It has cash and short-term investments of CN¥2.6B.
Belangrijke informatie
129.8%
Verhouding schuld/eigen vermogen
CN¥4.04b
Schuld
| Rente dekkingsratio | 4.9x |
| Contant | CN¥2.55b |
| Aandelen | CN¥3.11b |
| Totaal verplichtingen | CN¥4.64b |
| Totaal activa | CN¥7.75b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing
May 13Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)
Apr 25ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target
Apr 21Analyse van de financiële positie
Kortlopende schulden: 300138's short term assets (CN¥5.6B) exceed its short term liabilities (CN¥3.1B).
Langlopende schulden: 300138's short term assets (CN¥5.6B) exceed its long term liabilities (CN¥1.5B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 300138's net debt to equity ratio (47.7%) is considered high.
Schuld verminderen: 300138's debt to equity ratio has increased from 65.7% to 129.8% over the past 5 years.
Schuldendekking: 300138's debt is not well covered by operating cash flow (0.8%).
Rentedekking: 300138's interest payments on its debt are well covered by EBIT (4.9x coverage).